XY-0206 |
XY-0206 |
Phase 3 Clinical |
Nanjing University Of Chinese Medicine |
Solid tumours; Leukemia, Myeloid, Acute |
Details
|
Clifutinib Besylate |
|
Phase 3 Clinical |
Guangdong Dongyangguang Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
KC1036 |
KC1036; KC-1036 |
Phase 3 Clinical |
Beijing Konruns Pharmaceutical Co Ltd |
Hematologic Neoplasms; Solid tumours; Digestive System Neoplasms; Sarcoma, Ewing; Thymus Neoplasms; Esophageal Squamous Cell Carcinoma; Adenocarcinoma; Neoplasm Metastasis |
Details
|
SKLB-1028 |
SKLB-1028 |
Phase 3 Clinical |
Sichuan University, CSPC Pharmaceutical Group Ltd |
Solid tumours; Leukemia, Promyelocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute |
Details
|
Lestaurtinib |
SPM-924; A-154475.0; KT-5555; SP-924; CEP-701 |
Phase 3 Clinical |
Kyowa Hakko Kirin Co Ltd |
Leukemia, Myeloid; Bone Marrow Neoplasms; Leukemia; Polycythemia Vera; Prostatic Neoplasms; Psoriasis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neuroblastoma; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Thrombocythemia, Essential |
Details
|
HEC-73543 |
HEC-73543 |
Phase 3 Clinical |
Hec Pharm Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Crenolanib Besylate |
CP-868596-26; IND-112201; CP-868596; ARO-002; ARO-002-26 |
Phase 3 Clinical |
Pfizer Inc |
Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute; Glioma |
Details
|
HYML-122 |
HYML-122; CHMFL-FLT3-122 |
Phase 2 Clinical |
Hefei Academy Of Physical Sciences, Chinese Academy Of Sciences, Hefei Cosource Pharmaceuticals |
Leukemia, Myeloid, Acute |
Details
|
Ningetinib Tosylate |
CT-053-PTSA; CT-053 |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Intestinal Neoplasms; Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
MRX-2843 |
UNC-2371; UNC-2025; MRX-2843 |
Phase 2 Clinical |
University Of North Carolina At Chapel Hill |
Leukemia; Solid tumours; Neoplasms; Pathologic Processes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Leukemia, Myeloid, Acute; Neoplastic Processes; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Emavusertib |
AU-4948; CA-4948 |
Phase 2 Clinical |
Aurigene |
Anemia; Stomach Neoplasms; Esophageal Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Digestive System Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Pancreatic Ductal; Lymphoma, Non-Hodgkin; Gastrointestinal Neoplasms; Melanoma |
Details
|
Zotiraciclib |
TG-02; SB-1317 |
Phase 2 Clinical |
Syncore Biotechnology Co Ltd |
Glioblastoma; Neoplasms; Brain Neoplasms; Astrocytoma; Gliosarcoma; Glioma; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Hepatocellular |
Details
|
NMS-03592088 |
NMS-P088; NMS-03592088 |
Phase 2 Clinical |
Nerviano Medical Sciences Srl |
Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute |
Details
|
MAX-40279 |
MAX-40279-001; Max-40279; MAX-40279-01; MAX-4 |
Phase 2 Clinical |
Maxinovel Pharmaceuticals Co Ltd |
Solid tumours; Leukemia; Esophageal Neoplasms; Stomach Neoplasms; Idiopathic Pulmonary Fibrosis; Myelodysplastic Syndromes; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Neoplasm Metastasis |
Details
|
Merestinib |
5OGS5K699E; LY-2801653 |
Phase 2 Clinical |
Eli Lilly And Company |
Biliary Tract Neoplasms; Skin Melanoma; Bone metastases; Solid tumours; Neoplasms; Pancreatic Neoplasms; Microsatellite instability-high cancer; Lymphoma, Mantle-Cell; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Fms-like tyrosine kinase 3 ligand (Celldex Therapeutics) |
CDX-301 |
Phase 2 Clinical |
Amgen Inc |
Sarcoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Leukemia, Myeloid, Acute; Carcinoma, Squamous Cell; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Osteosarcoma; Skin Melanoma; Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Myelodysplastic Syndromes; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Leukemia, Myelogenous, Chronic |
Details
|
Tuspetinib |
HM-43239 |
Phase 2 Clinical |
Hanmi Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Flysyn |
4G8-SDIEM |
Phase 2 Clinical |
Synimmune Gmbh |
Leukemia, Myeloid, Acute |
Details
|
Glesatinib |
MGCD-265; MG-90265X; 7Q29OXD98N; MG-90265H9; MG-90265gly; MG-90265 |
Phase 2 Clinical |
Mirati Therapeutics Inc |
Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
FF-10101 |
FF-10101; FF-10101-01; FF-10101 succinate |
Phase 2 Clinical |
Fujifilm Corp |
Leukemia, Myeloid, Acute |
Details
|
Sorafenib Tosylate/Comekibart |
MG-D-1609 |
Phase 2 Clinical |
Metagone Biotech Inc |
Solid tumours |
Details
|
Anti-FLT3 CAR-T Cell Therapy (PersonGen Biomedicine) |
TAA05 |
Phase 2 Clinical |
Persongen Biotherapeutics (Suzhou) Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Flonoltinib maleate |
|
Phase 2 Clinical |
Chengdu Zenitar Biomedical Technology Co Ltd |
Polycythemia Vera; Alopecia Areata; Myeloproliferative Disorders; Primary Myelofibrosis; Lymphohistiocytosis, Hemophagocytic; Thrombocythemia, Essential |
Details
|
EP-0042 |
EP-0042 |
Phase 2 Clinical |
Ellipses Pharma |
Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
MEN-1703 |
SEL-24-1; MEN-1703; SEL24/MEN1703; SEL24; SEL-24; SEL-24-B489 |
Phase 2 Clinical |
Ryvu Therapeutics Sa |
Leukemia, Myeloid, Acute |
Details
|
FN-1501 |
FN-1501; LT-171-861 |
Phase 2 Clinical |
China Pharmaceutical University, Shanghai Fosun Pharmaceutical Industrial Development Co Ltd |
Solid tumours; Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Hepatocellular |
Details
|
Mivavotinib |
TAK-659; CB-659 |
Phase 1 Clinical |
Takeda Pharmaceutical Co Ltd |
Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Plasmablastic Lymphoma; Lymphoma, Follicular; Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung |
Details
|
Emirodatamab |
AMG-427 |
Phase 1 Clinical |
Amgen Inc |
Leukemia, Myeloid, Acute |
Details
|
E-6201 |
E-6201 |
Phase 1 Clinical |
Eisai Co Ltd |
Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Psoriasis; Brain metastases; Leukemia, Myeloid, Acute; Melanoma |
Details
|
SENTI-202 |
SENTI-202 |
Phase 1 Clinical |
Senti Biosciences Inc |
Hematologic Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
ETH-155008 |
ETH-155008 |
Phase 1 Clinical |
Yunnan Shengke Pharmaceutical Co Ltd |
Leukemia; Leukemia, Promyelocytic, Acute; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute |
Details
|
CLN-049 |
CLN-049 |
Phase 1 Clinical |
University Of Tubingen, German Cancer Research Center (Dkfz) |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
QBH-196 |
QBH-196 |
Phase 1 Clinical |
Shenyang Pharmaceutical University |
Solid tumours; Stomach Neoplasms |
Details
|
ETN-101 |
ETN101; ETN-101; MBP-11901 |
Phase 1 Clinical |
Etnova Therapeutics Corp |
Liver Neoplasms; Carcinoma, Hepatocellular |
Details
|
Lomonitinib |
|
Phase 1 Clinical |
Eilean Therapeutics LLC |
|
Details
|
KME-0584 |
KME-0584 |
Phase 1 Clinical |
National Center For Advancing Translational Sciences, Cincinnati Children'S Hospital Medical Center |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
Lomonitinib |
ZE46-0134; ZE-46-0134; ZE-460134 |
Phase 1 Clinical |
Eilean Therapeutics LLC |
Leukemia, Promyelocytic, Acute; Leukemia, Myeloid, Acute |
Details
|
ETH-155036 |
ETH-155036; ETH155036 |
Phase 1 Clinical |
Shengke Pharmaceutical (Jiangsu) Co Ltd |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
BMF-500 |
BMF-500 |
Phase 1 Clinical |
Biomea Fusion Inc |
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
TT-00973 |
TT-00973 |
Phase 1 Clinical |
TransThera Sciences (Nanjing) Inc |
Solid tumours |
Details
|
PHI-101 |
PHI-101; PHI-101-002; PHI-101-003 |
Phase 1 Clinical |
Pharos iBio Co Ltd |
Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute |
Details
|
LNK-01002 |
LNK01002 |
Phase 1 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Hematologic Neoplasms; Polycythemia Vera; Myeloproliferative Disorders; Primary Myelofibrosis; Leukemia, Myeloid, Acute |
Details
|
SKI-G-801 |
G-801; SKI-G-801; G-749 Hydrochloride |
Phase 1 Clinical |
Oscotec Inc |
Solid tumours; Leukemia, Myeloid, Acute |
Details
|
Luxeptinib |
CG-806; CG-026806 |
Phase 1 Clinical |
Crystalgenomics Inc, Aptose |
Myelodysplastic Syndromes; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
XY-0206 |
XY-0206 |
Phase 3 Clinical |
Nanjing University Of Chinese Medicine |
Solid tumours; Leukemia, Myeloid, Acute |
Details
|
Clifutinib Besylate |
|
Phase 3 Clinical |
Guangdong Dongyangguang Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
KC1036 |
KC1036; KC-1036 |
Phase 3 Clinical |
Beijing Konruns Pharmaceutical Co Ltd |
Hematologic Neoplasms; Solid tumours; Digestive System Neoplasms; Sarcoma, Ewing; Thymus Neoplasms; Esophageal Squamous Cell Carcinoma; Adenocarcinoma; Neoplasm Metastasis |
Details
|
SKLB-1028 |
SKLB-1028 |
Phase 3 Clinical |
Sichuan University, CSPC Pharmaceutical Group Ltd |
Solid tumours; Leukemia, Promyelocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute |
Details
|
Lestaurtinib |
SPM-924; A-154475.0; KT-5555; SP-924; CEP-701 |
Phase 3 Clinical |
Kyowa Hakko Kirin Co Ltd |
Leukemia, Myeloid; Bone Marrow Neoplasms; Leukemia; Polycythemia Vera; Prostatic Neoplasms; Psoriasis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neuroblastoma; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Thrombocythemia, Essential |
Details
|
HEC-73543 |
HEC-73543 |
Phase 3 Clinical |
Hec Pharm Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Crenolanib Besylate |
CP-868596-26; IND-112201; CP-868596; ARO-002; ARO-002-26 |
Phase 3 Clinical |
Pfizer Inc |
Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute; Glioma |
Details
|
HYML-122 |
HYML-122; CHMFL-FLT3-122 |
Phase 2 Clinical |
Hefei Academy Of Physical Sciences, Chinese Academy Of Sciences, Hefei Cosource Pharmaceuticals |
Leukemia, Myeloid, Acute |
Details
|
Ningetinib Tosylate |
CT-053-PTSA; CT-053 |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Intestinal Neoplasms; Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
MRX-2843 |
UNC-2371; UNC-2025; MRX-2843 |
Phase 2 Clinical |
University Of North Carolina At Chapel Hill |
Leukemia; Solid tumours; Neoplasms; Pathologic Processes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Leukemia, Myeloid, Acute; Neoplastic Processes; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Emavusertib |
AU-4948; CA-4948 |
Phase 2 Clinical |
Aurigene |
Anemia; Stomach Neoplasms; Esophageal Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Digestive System Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Pancreatic Ductal; Lymphoma, Non-Hodgkin; Gastrointestinal Neoplasms; Melanoma |
Details
|
Zotiraciclib |
TG-02; SB-1317 |
Phase 2 Clinical |
Syncore Biotechnology Co Ltd |
Glioblastoma; Neoplasms; Brain Neoplasms; Astrocytoma; Gliosarcoma; Glioma; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Hepatocellular |
Details
|
NMS-03592088 |
NMS-P088; NMS-03592088 |
Phase 2 Clinical |
Nerviano Medical Sciences Srl |
Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute |
Details
|
MAX-40279 |
MAX-40279-001; Max-40279; MAX-40279-01; MAX-4 |
Phase 2 Clinical |
Maxinovel Pharmaceuticals Co Ltd |
Solid tumours; Leukemia; Esophageal Neoplasms; Stomach Neoplasms; Idiopathic Pulmonary Fibrosis; Myelodysplastic Syndromes; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Neoplasm Metastasis |
Details
|
Merestinib |
5OGS5K699E; LY-2801653 |
Phase 2 Clinical |
Eli Lilly And Company |
Biliary Tract Neoplasms; Skin Melanoma; Bone metastases; Solid tumours; Neoplasms; Pancreatic Neoplasms; Microsatellite instability-high cancer; Lymphoma, Mantle-Cell; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Fms-like tyrosine kinase 3 ligand (Celldex Therapeutics) |
CDX-301 |
Phase 2 Clinical |
Amgen Inc |
Sarcoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Leukemia, Myeloid, Acute; Carcinoma, Squamous Cell; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Osteosarcoma; Skin Melanoma; Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Myelodysplastic Syndromes; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Leukemia, Myelogenous, Chronic |
Details
|
Tuspetinib |
HM-43239 |
Phase 2 Clinical |
Hanmi Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Flysyn |
4G8-SDIEM |
Phase 2 Clinical |
Synimmune Gmbh |
Leukemia, Myeloid, Acute |
Details
|
Glesatinib |
MGCD-265; MG-90265X; 7Q29OXD98N; MG-90265H9; MG-90265gly; MG-90265 |
Phase 2 Clinical |
Mirati Therapeutics Inc |
Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
FF-10101 |
FF-10101; FF-10101-01; FF-10101 succinate |
Phase 2 Clinical |
Fujifilm Corp |
Leukemia, Myeloid, Acute |
Details
|
Sorafenib Tosylate/Comekibart |
MG-D-1609 |
Phase 2 Clinical |
Metagone Biotech Inc |
Solid tumours |
Details
|
Anti-FLT3 CAR-T Cell Therapy (PersonGen Biomedicine) |
TAA05 |
Phase 2 Clinical |
Persongen Biotherapeutics (Suzhou) Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Flonoltinib maleate |
|
Phase 2 Clinical |
Chengdu Zenitar Biomedical Technology Co Ltd |
Polycythemia Vera; Alopecia Areata; Myeloproliferative Disorders; Primary Myelofibrosis; Lymphohistiocytosis, Hemophagocytic; Thrombocythemia, Essential |
Details
|
EP-0042 |
EP-0042 |
Phase 2 Clinical |
Ellipses Pharma |
Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
MEN-1703 |
SEL-24-1; MEN-1703; SEL24/MEN1703; SEL24; SEL-24; SEL-24-B489 |
Phase 2 Clinical |
Ryvu Therapeutics Sa |
Leukemia, Myeloid, Acute |
Details
|
FN-1501 |
FN-1501; LT-171-861 |
Phase 2 Clinical |
China Pharmaceutical University, Shanghai Fosun Pharmaceutical Industrial Development Co Ltd |
Solid tumours; Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Hepatocellular |
Details
|
Mivavotinib |
TAK-659; CB-659 |
Phase 1 Clinical |
Takeda Pharmaceutical Co Ltd |
Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Plasmablastic Lymphoma; Lymphoma, Follicular; Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung |
Details
|
Emirodatamab |
AMG-427 |
Phase 1 Clinical |
Amgen Inc |
Leukemia, Myeloid, Acute |
Details
|
E-6201 |
E-6201 |
Phase 1 Clinical |
Eisai Co Ltd |
Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Psoriasis; Brain metastases; Leukemia, Myeloid, Acute; Melanoma |
Details
|
SENTI-202 |
SENTI-202 |
Phase 1 Clinical |
Senti Biosciences Inc |
Hematologic Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
ETH-155008 |
ETH-155008 |
Phase 1 Clinical |
Yunnan Shengke Pharmaceutical Co Ltd |
Leukemia; Leukemia, Promyelocytic, Acute; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute |
Details
|
CLN-049 |
CLN-049 |
Phase 1 Clinical |
University Of Tubingen, German Cancer Research Center (Dkfz) |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
QBH-196 |
QBH-196 |
Phase 1 Clinical |
Shenyang Pharmaceutical University |
Solid tumours; Stomach Neoplasms |
Details
|
ETN-101 |
ETN101; ETN-101; MBP-11901 |
Phase 1 Clinical |
Etnova Therapeutics Corp |
Liver Neoplasms; Carcinoma, Hepatocellular |
Details
|
Lomonitinib |
|
Phase 1 Clinical |
Eilean Therapeutics LLC |
|
Details
|
KME-0584 |
KME-0584 |
Phase 1 Clinical |
National Center For Advancing Translational Sciences, Cincinnati Children'S Hospital Medical Center |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
Lomonitinib |
ZE46-0134; ZE-46-0134; ZE-460134 |
Phase 1 Clinical |
Eilean Therapeutics LLC |
Leukemia, Promyelocytic, Acute; Leukemia, Myeloid, Acute |
Details
|
ETH-155036 |
ETH-155036; ETH155036 |
Phase 1 Clinical |
Shengke Pharmaceutical (Jiangsu) Co Ltd |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
BMF-500 |
BMF-500 |
Phase 1 Clinical |
Biomea Fusion Inc |
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
TT-00973 |
TT-00973 |
Phase 1 Clinical |
TransThera Sciences (Nanjing) Inc |
Solid tumours |
Details
|
PHI-101 |
PHI-101; PHI-101-002; PHI-101-003 |
Phase 1 Clinical |
Pharos iBio Co Ltd |
Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute |
Details
|
LNK-01002 |
LNK01002 |
Phase 1 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Hematologic Neoplasms; Polycythemia Vera; Myeloproliferative Disorders; Primary Myelofibrosis; Leukemia, Myeloid, Acute |
Details
|
SKI-G-801 |
G-801; SKI-G-801; G-749 Hydrochloride |
Phase 1 Clinical |
Oscotec Inc |
Solid tumours; Leukemia, Myeloid, Acute |
Details
|
Luxeptinib |
CG-806; CG-026806 |
Phase 1 Clinical |
Crystalgenomics Inc, Aptose |
Myelodysplastic Syndromes; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|